← Eichor
Condition: Antifibrinolytic Agents Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antifibrinolytic Agents

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery
Phase 4 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06128330Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT03582293Tranexamic Acid to Reduce Blood Loss in Spine Surgery
Phase 2/Phase 3 · 4 location(s) · Columbia University · NCT02314988Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk
Phase 3 · 1 location(s) · London School of Hygiene and Tropical Medicine · NCT05562609
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.